1989
DOI: 10.1016/s0033-3182(89)72297-0
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Behavioral Problems with Pindolol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

1990
1990
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(14 citation statements)
references
References 12 publications
0
14
0
Order By: Relevance
“…Propranolol and pindolol have been most extensively studied, based on the theory that higher lipophilicity is required for central nervous system effects. [10][11][12][13] The exact mechanism of action is unclear but is theorized to involve a dampening of exaggerated adrenergic responses in patients with TBI, and perhaps additional 5-HT1A partial agonist activity in the case of pindolol. There is increasing evidence of mortality benefits with the use of various beta-blockers immediately post-TBI, though more work is needed to delineate the best timing and selection of agents.…”
Section: Clinical Presentation and Treatment Considerationsmentioning
confidence: 99%
“…Propranolol and pindolol have been most extensively studied, based on the theory that higher lipophilicity is required for central nervous system effects. [10][11][12][13] The exact mechanism of action is unclear but is theorized to involve a dampening of exaggerated adrenergic responses in patients with TBI, and perhaps additional 5-HT1A partial agonist activity in the case of pindolol. There is increasing evidence of mortality benefits with the use of various beta-blockers immediately post-TBI, though more work is needed to delineate the best timing and selection of agents.…”
Section: Clinical Presentation and Treatment Considerationsmentioning
confidence: 99%
“…The 2008 Cochrane review7 of the pharmacological management of agitation and aggression in individuals with ABI identified six randomised controlled trials (RCTs) (Greendyke et al ,810 Brooke et al ,11 Mooney and Haas12 and Schneider et al 13), none of which evaluate the use of CBZ. Four of the six RCTs investigated the role of beta-blockers.…”
Section: Commentarymentioning
confidence: 99%
“…These have generally been found to be effective in younger patients with evidence of brain damage, and several reports have suggested that pindolol may be effective in dementia. It has the advantage of pure cardiovascular side effects (Greendyke & Kanter, 1986;Greendyke et al, 1989).…”
Section: P-blockersmentioning
confidence: 99%